Best Breast Cancer Trial Ever Known: 5 Times Less Mortality
(for Breathing Normalization Group)
Medical professionals have failed to understand and explain to the general public and cancer patients that overbreathing (or hyperventilation) reduces one's body oxygen level due to 3 fundamental laws
of respiratory physiology:
1. When we hyperventilate (breathe more than the
medical norm), we cannot improve oxygen content in the hemoglobin of the arterial
blood (red blood cells are about 98% saturated with oxygen during
tiny normal breathing).
2. Overbreathing reduces the CO2 concentration in the arterial blood causing
a constriction of arteries and arterioles since
CO2 is a powerful vasodilator. Hence,
hyperventilation results in reduced perfusion and oxygen supply (confirmed
by tens of published medical studies) for the liver, brain, heart, kidneys,
stomach, colon, and other vital organs.
3. Reduced CO2 value in the tissues produces a shift in the O2
dissociation curve to the left. This leads to the so-called shallow or suppressed
Bohr effect (a reduced O2 release by red blood cells in the capillaries).
Therefore, the more a cancer patient breathes beyond the norm, the less oxygen is provided for
the heart, brain, kidneys, liver, and other vital organs. Reduced cellular
oxygenation leads to anaerobic mitochondrial metabolism,
elevated lactic acid values, the formation of free radicals, and cell acidosis
or a lowered pH in cells. On the contrary, CO2 is a chemical that is needed
for tumor treatment, as numerous studies on
carbogen use in cancer
Cancer patients, as it has been shown by
numerous published studies,
breathe more frequently than the norm. Typical breathing frequencies in
advanced cancer patients are about 26-30, in some studies more than 40
breaths per minute. (This parameter cannot be measured by the cancer
patient herself, due to changes in the breathing pattern, but can be
easily defined by others when she is at rest or during non-REM sleep.
The official norm is 10-12 breaths per minute at rest.)
Since the growth of tumors depend on one's body oxygen level, chronic
hyperventilation promotes the growth of malignant cells and metastasis. These processes are manifested in a lower CP (DIY body oxygen test) in cancer patients. Therefore, breathing normalization and the correction of risk lifestyle factors must be a central part of any successful anti-cancer program or cancer cure.
Let us consider how breathing normalization influences survival and
other parameters of cancer patients in this clinical trial ("Study of application of the shallow breathing method in a combined treatment of breast cancer", but in Russian).
Greatest success in all breast cancer clinical trials
The clinical trial was conducted by Sergey Paschenko, MD, a pupil of
Dr. Konstantin Buteyko (the author of the Buteyko breathing method). The
study was published by the Ukrainian National Journal of Oncology (Kiev,
2001, v. 3, No.1, p. 77-78, “Study of application of the shallow
breathing method in a combined treatment of breast cancer”).
Clearly, it is not the name of the breathing technique, but the practical
achievement of normal breathing parameters that should matter most for
the wellbeing of the patient, body oxygenation, and cancer prevention.
In this study, Dr. S. Paschenko applied a modified breath-retraining
technique based on the same principal idea: reduced breathing. Reduced
breathing sessions are based on breathing slightly less than usual,
while having correct posture and an empty stomach. Instead of having
large inhalations, the patient is suggested to have shorter inhalations
using the diaphragm only and to continuously maintain a light, but
comfortable desire to breathe more frequently (or an air hunger) coupled
with the relaxation of the diaphragm for exhalations and all other parts and
muscles of the human body. In this clinical trial, the total duration of shallow
muscles of the human body. In this clinical trial, the total duration of shallow
breathing exercises ranged from 60 minutes up to 2.5-4 hours per day for
3 years. Breathing sessions ranged from 20 to 30 min long.
One hundred twenty patients with breast cancer (T1-2N1M0)
participated in this study. (These letters and numbers relate to cancer
parameters. For T1-2: the tumors are less than 5 cm or 2 inches in size;
N1: cancer has spread to 1 to 3 axillary (underarm) lymph nodes,
and/or tiny amounts of cancer are found in internal mammary lymph nodes
(those near the breast bone) on sentinel lymph node biopsy; M0: no
distant metastasis). All patients had a standard anti-cancer therapy
that included the surgical removal of tumors. However, in addition to this
therapy, the breathing retraining group (67 patients) practiced shallow
breathing exercises. Their parameters were compared with the control
group (the remaining 53 patients).
From my view, as I also teach breathing retraining, the most amazing
and excellent fact of this very successful clinical trial is that the breathing teacher and his
students were persevering with breathing retraining for at least 3
years, indicating their courage and self-discipline. The breathing
retraining group increased their exhaled CO2 content by almost double.
If we assume that their metabolic rate (or CO2 production rate) remained
the same, their minute ventilation (amount of air inhaled in one minute)
was reduced about 2 times. Hence, as a result of breathing retraining
they started to breathe about 2 times less. Unfortunately, the author
did not specify the details of his CO2 measurement method. Most likely,
his CO2 values relate to CO2 concentrations during the last part of the
exhalation (not the total CO2 content of all exhaled air). This assumption
allows us to evaluate the CP changes before and during breathing
The CP (control pause or body oxygen level) is the breath
holding time after usual exhalation and is discontinued at the first
signs of stress or discomfort (without pushing yourself for larger
numbers). Practical evidence, as well as physiological laws indicate that the less one breathes, the higher his or her CP. Hence, it is logical that
the Buteyko breathing method is based on activities and lifestyle
factors that make breathing lighter, while the CP test is the main test
to measure personal progress.
When people have normal breathing (the official medical norm
corresponds to 6 breaths per min at rest for a 70-kg man), their CP is
about 40 seconds. The normal CO2 content in the second half of the
exhaled air is about 5-5.5%. Such breathing is invisible and inaudible.
It is so tiny that normal breathers do not have the sensation of air
movements and generally claim that they feel their own breathing.
(People who practice breathing exercises sharpen their sensations and
can feel air flow and miniscule breathing movements.)
For this study, the patients had significantly lower CO2
concentrations in the exhaled air, indicating the presence of chronic
hyperventilation. The predicted initial CPs for both groups was between
about 10 and 20 seconds. After 3 years of breathing retraining, the
patients who practiced shallow breathing exercises breathed even less than the
official medical norm and closer to the Buteyko’ breathing norm (or 4
l/min for minute ventilation, 8 breaths/min for breathing frequency, and
60 s for the CP).
When the health state of some patients dramatically worsened
(metastasis), their exhaled CO2 content dropped about 2 times from their
initial values. This indicates severe chronic hyperventilation and their
CPs were down to 5-10 s only.
Due to technical difficulties, the author did not provide expired CO2
values during the last hours of sleep. However, numerous medical
epidemiological studies have shown that exacerbations of chronic
diseases, as well as the highest mortality rates for heart disease, asthma,
COPD, stroke, diabetes, epilepsy, and many other conditions, take place
during early morning hours (from about 4 to 7 am), when breathing is
heaviest and the CP is shortest due to the
Morning Hyperventilation Effect. Practically, evening-to-morning CP
drops in the sick can vary from 3 to about 15 s or up to about 2-3 times in
average. Since cancer has some similarities to severe inflammatory
diseases (large masses of abnormal cells), the intensification of breathing
during night sleep and a large overnight CP drop are normal.
Conclusions. These general observations in relation to breathing rates, CO2
values, CP numbers and quality-of-life factors, mentioned by the author,
are in agreement with the
Buteyko Table of
Health Zones. Three-year
mortality rate for the breathing normalization group was 4.5% and for
the control group 24.5%. Hence, breathing normalization decreased a 3-year
mortality by more than 5 times. All patients who normalized their
Important practical note. Since the Frolov device produces even
faster and better results than Buteyko breathing exercises, the smartest
method to deal with low CO2, O2 and cancer is to use the Frolov device with
Buteyko lifestyle factors.
My translation of this trial, as well as the link to the PDF file, of this trial "Study of application of the shallow breathing method in a combined treatment of breast cancer" can be found right below here as your bonus content.
Tweet or Share this page to reveal the bonus content.